Aytu Biopharma, Inc. (AYTU)
2.25
+0.01
(+0.45%)
USD |
NASDAQ |
Dec 09, 16:00
2.23
-0.02
(-0.89%)
After-Hours: 20:00
Aytu Biopharma EPS Diluted (Quarterly): -0.0773 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Omeros Corp. | -0.4666 |
| GeoVax Labs, Inc. | -0.3115 |
| Vistagen Therapeutics, Inc. | -0.5432 |
| Precigen, Inc. | -1.059 |
| Daré Bioscience, Inc. | -0.2793 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 1.965M |
| Revenue (Quarterly) | 13.89M |
| Total Expenses (Quarterly) | 11.92M |
| Enterprise Value | 18.70M |
| Gross Profit Margin (Quarterly) | 62.95% |
| Profit Margin (Quarterly) | 14.15% |
| Earnings Yield | -135.4% |
| Operating Earnings Yield | 4.88% |
| Normalized Earnings Yield | -92.73 |